Baudax Bio Inc (BXRX)

NASDAQ
0.5834
-0.0182(-3.03%)
  • Volume:
    451,057
  • Bid/Ask:
    0.5817/0.5870
  • Day's Range:
    0.5800 - 0.5950

BXRX Overview

Prev. Close
0.6016
Day's Range
0.58-0.595
Revenue
700K
Open
0.578
52 wk Range
0.571-3.93
EPS
-1.91
Volume
451,057
Market Cap
50.7M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,705,468
P/E Ratio
-
Beta
-
1-Year Change
-83.34%
Shares Outstanding
84,273,222
Next Earnings Date
Aug 05, 2021
What is your sentiment on Baudax Bio Inc?
or
Vote to see community's results!

Baudax Bio Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Baudax Bio Inc Company Profile

Baudax Bio Inc Company Profile

Employees
57

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; BX2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and BX3000, an NMBA reversal agent, which is under pre-clinical trial, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine, which is under phase II clinical trial. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.

Read More
  • the analysts from Investing.com said BXRX 1-year target at $13. now BXRX is below $1. 😵
    0
    • The future is unknown. It's just the range of predictions. It seems that the predicted person is selling
      0
    • hahaha
      0
    • their products still phase 1 so it can take another 2 years perhaps before it reached phase 3 so for now better steep
      0
  • see! BXRX cannot move up, that is totally manipulated by insiders.
    0
    • every buyer is so tired of the this puppy.
      1
      • why did those analysts target BXRX $12? it is now a penny stock. crazy!
        0
        • I believe once surgeries start to be common again, BXRX is going to up.
          0
      • BZRX dropped all the way in the past 2 years. the CEO seems does not care about this company. no wonder the hedge funds still short this stock.
        0
        • this stock is only available as from November 2019 (less than 2 years)...if it goes down to 0.90s range it is a great price to buy.
          0
      • BXRX is dying.... see you at 90 cents again
        2
        • Dont hold your breath dear...
          0
      • Buy now as this is going up
        0
        • They are sinking big money into their FDA approved non-opiod pain drug. 3.50 by end of this year if they follow through with their promises.
          0
          • We can see under 1$. It doesn’t mean, will hit more than 3$ after Q2.
            0
            • BXRX is heading to $1.1 again. watch & learn.
              1
              • 11 strong sell, 1 buy. terrible! see you at $1
                2
                • BXRX will fall below $1 very soon.
                  2
                  • i dont think so
                    0
                • It seems to be reacting to the earnings miss. What is the outlook for this stock?
                  0
                  • Why this stock did not react when announcing previous earnings
                    0
                    • good earnings? why are so may hedge funds still shorting BXRX??? doesn't make sense.
                      0
                      • let's make a "Reddit" to the shorts!!!!
                        1
                    • ...good results...its a growning company !
                      0
                      • what happens to BXRX? still so many hedge funds love to sellshort it. BXRX should hit at least $5.
                        0
                        • did you see the earnings today ??....not as expected...
                          0
                      • this little giant is Waking up from the nap! 🙂🚀
                        0
                        • BXRX dropped because some hedge funds still short BXRX. once the company announce god news, those hedge funds will be forced to cover their short positions. then BXRX will hit $3.
                          0
                          • 📈🚀⏳
                            0
                            • What's going on? why is falling like that?
                              0
                              • BXRX may announce new drug results soon. get ready ladies & gentlemen.....🚀🚀🚀
                                0
                                • the company needs to release some news to attract more investors.
                                  0
                                  • what is the logical buy point? glad to hear your ideas?
                                    0
                                    • I dont understand y direct offering perceived as negative news .
                                      0
                                    • This stock has great potential. its a relatively new stock when compared to others. Its on a rise. Buy the dip and hold.
                                      0
                                  • BXRX I as ready to pop. the hedge funds will be forced to cover their short position very soon. $12-$13 target price is possible.....
                                    0
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.